MetaSight Diagnostics
Latest round
- Series A
Last raised
- Nov 2024
Total raised
- $8M
Investors
- 4
About MetaSight Diagnostics
MetaSight Diagnostics Ltd, founded in 2021 and headquartered in Rehovot, Israel, specializes in innovative diagnostics.MetaSight specializes in developing innovative disease diagnostics and monitoring solutions through advanced blood testing methodologies. Their core offerings are based on proprietary high-throughput mass-spectrometry multi-OMICs technology that analyzes biological samples at a molecular level. This technology includes population-scale serum sample collection and continuous access to electronic health records, addressing significant healthcare challenges in early disease detection and monitoring.MetaSight's revenue model is primarily based on partnerships and clinical studies leveraging its advanced diagnostic technologies. The company collaborates with healthcare institutions and laboratories, providing access to its diagnostic tools and supporting services. Clients typically enter agreements for large-scale screening initiatives, such as the Israel Multi-OMICS Screening Trial, which has engaged over half a million participants. The company aims to broaden its market reach, targeting new geographical regions for expansion, although specific locations have not been disclosed.
Who invested in MetaSight Diagnostics
4 investors across 1 round
See all investors in MetaSight Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 13, 2024
Amount
$8M
Investors
Questions about MetaSight Diagnostics
Who invested in MetaSight Diagnostics?
MetaSight Diagnostics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MetaSight Diagnostics raised?
MetaSight Diagnostics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did MetaSight Diagnostics last raise money?
MetaSight Diagnostics's most recent round on record is a Series A, in Nov 2024.
What does MetaSight Diagnostics do?
MetaSight Diagnostics Ltd, founded in 2021 and headquartered in Rehovot, Israel, specializes in innovative diagnostics.
Where is MetaSight Diagnostics headquartered?
MetaSight Diagnostics is headquartered in Rehovot, Israel.
Which VCs invest in companies like MetaSight Diagnostics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at MetaSight Diagnostics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like MetaSight Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.